Literature DB >> 10557086

Involvement of Notch1 in the development of mouse mammary tumors.

A Diévart1, N Beaulieu, P Jolicoeur.   

Abstract

The MMTV/neu transgenic (Tg) mice spontaneously develop mammary tumors stochastically after a long latent period, suggesting that the c-neu/erbB2 oncogene is not sufficient for tumor formation. To identify putative collaborator(s) of the c-neu/erbB2, we used the provirus insertional mutagenesis approach with mammary tumors arising in MMTV/neu Tg mice infected with the mouse mammary tumor virus (MMTV). The Notch1 gene was identified as a novel target for MMTV provirus insertional activation. In Notch1-rearranged tumors, the Notch1 gene was interrupted by the MMTV provirus insertion upstream of the exons coding for the TM domain. These insertions led to overexpression of novel 5' truncated approximately 7 kb RNA coding for 280 kDa mutant protein harboring only the Notch1 ectodomain, N(EC)mut. These may be involved in tumor formation. Another consequence of these insertions was the expression of truncated 3' Notch1 transcripts (3.5 - 4.5 kb) and proteins (86 - 110 kDa) deleted of most of the extracellular sequences (Notch1intra). We found that 3' truncated Notch1intra can transform HC11 mouse mammary epithelial cells in vitro. Deletion analysis revealed that the ankyrin-repeats and the domain 1 (aa 1751 - 1821) are required, while a signal peptide, the two conserved cysteines (C1652 and C1685) and the OPA and PEST sequences are dispensable for transformation. These results indicate that the N-terminally truncated Notch1intra protein behaves as an oncogene in this system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557086     DOI: 10.1038/sj.onc.1202991

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  74 in total

1.  Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.

Authors:  Gouri Chatterjee; Andrea Rosner; Yi Han; Edward T Zelazny; Baolin Li; Robert D Cardiff; Archibald S Perkins
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells.

Authors:  Sungpil Cho; Meiling Lu; Xiaolong He; Pui-Lai Rachel Ee; Uppoor Bhat; Erasmus Schneider; Lucio Miele; William T Beck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 3.  Notch signaling in mammary development and oncogenesis.

Authors:  Robert Callahan; Sean E Egan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

4.  ErbB2 induces Notch1 activity and function in breast cancer cells.

Authors:  Jaime Lindsay; Xuanmao Jiao; Toshiyuki Sakamaki; Mathew C Casimiro; Lawrence A Shirley; Thai H Tran; Xiaoming Ju; Manran Liu; Zhiping Li; Chenguang Wang; Sanjay Katiyar; Mahadev Rao; Kathleen G Allen; Robert I Glazer; Changhui Ge; Pamela Stanley; Michael P Lisanti; Hallgeir Rui; Richard G Pestell
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

Review 5.  Therapeutic approaches to modulating Notch signaling: current challenges and future prospects.

Authors:  Casper Groth; Mark E Fortini
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

6.  Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice.

Authors:  Apostolos Klinakis; Matthias Szabolcs; Katerina Politi; Hippokratis Kiaris; Spyros Artavanis-Tsakonas; Argiris Efstratiadis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

Review 7.  Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.

Authors:  Wen Shi; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

8.  Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.

Authors:  Paola Rizzo; Haixi Miao; Gwendolyn D'Souza; Clodia Osipo; Lynda L Song; Jieun Yun; Huiping Zhao; Joaquina Mascarenhas; Debra Wyatt; Giovanni Antico; Lu Hao; Katharine Yao; Prabha Rajan; Chindo Hicks; Kalliopi Siziopikou; Suzanne Selvaggi; Amina Bashir; Deepali Bhandari; Adriano Marchese; Urban Lendahl; Jian-Zhong Qin; Debra A Tonetti; Kathy Albain; Brian J Nickoloff; Lucio Miele
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

9.  Notch3 functions as a tumor suppressor by controlling cellular senescence.

Authors:  Hang Cui; Yahui Kong; Mei Xu; Hong Zhang
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

10.  Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim.

Authors:  J Konishi; F Yi; X Chen; H Vo; D P Carbone; T P Dang
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.